Cleveland Clinic Releases Fourth Installment of Annual Alzheimer's Disease Drug Development Pipeline Report
July 10, 2019
July 10, 2019
CLEVELAND, Ohio, July 10 -- The Cleveland Clinic issued the following news release:
* * *
- Despite several high profile failures, Alzheimer's drug development continues with a diverse pipeline beyond amyloid
* * *
Cleveland Clinic's fourth annual analysis of Alzheimer's disease drug development found that the pipeline has grown in the number and variety of agents being tested over the past year, while highlighting several advances in the field . . .
* * *
- Despite several high profile failures, Alzheimer's drug development continues with a diverse pipeline beyond amyloid
* * *
Cleveland Clinic's fourth annual analysis of Alzheimer's disease drug development found that the pipeline has grown in the number and variety of agents being tested over the past year, while highlighting several advances in the field . . .